Pharmaceutical

FDA grants fast track designation to AskBio’s AB-1005 for PD

Bayer and Asklepios BioPharmaceutical (AskBio) have announced FDA fast track designation for AB-1005, a gene therapy for PD.

Jul 14, 2024 - 04:00
FDA grants fast track designation to AskBio’s AB-1005 for PD
Bayer and Asklepios BioPharmaceutical (AskBio) have announced FDA fast track designation for AB-1005, a gene therapy for PD.
Read the original article

Tags:

Previous Article

Ipsen gains global rights to Foreseen Biotech’s FS001 ADC

Next Article

Pan Cancer T raises funds through seed extension round

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: A controversial new study examines traditional Chinese medicine’s potential cardiac benefits

STAT+: A controversial new study examines traditional C...

Oct 24, 2023

Kellogg’s is going to war over Mexico’s nutrition label rules. A similar fight is coming to the U.S.

Kellogg’s is going to war over Mexico’s nutrition label...

Aug 21, 2023

Opinion: What Rosalynn Carter understood about mental health

Opinion: What Rosalynn Carter understood about mental h...

Nov 21, 2023